Alambic Investment Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-308
Closed -$141K 474
2018
Q1
$141K Sell
308
-63
-17% -$28.8K 0.02% 425
2017
Q4
$214K Buy
+371
New +$214K 0.03% 406